Corrigendum to “Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population” (Prog. Neuro-Psychopharmacol. Biol. Psychiatry, (2012) 36 (17–21) (S0278584611002806) (10.1016/j.pnpbp.2011.09.011));Analysis of association between common SNPs in ErbB4 and bipolar affective disorder, major depressive disorder and schizophrenia in the Han Chinese population

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 36, Issue 1, 2012, Pages 17-21

  Chen, Peng ^a   Chen, Jianhua ^a   Huang, Ke ^a   Ji, Weidong ^a   Wang, Ti ^a   Li, Tao ^a   Wang, Yang ^a   Wang, Hankun ^a   He, Lin ^a,b,c   Feng, Guoyin ^a   Shi, Yongyong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b Shanghai Jiao Tong University Affiliated Sixth People s Hospital   (China)

^c FUDAN UNIVERSITY   (China)

Author keywords

Bipolar affective disorder; Case control study; ErbB4; Genetic association; Major depressive disorder; Schizophrenia

Indexed keywords

ADULT; ARTICLE; BIPOLAR DISORDER; CHINESE; CONTROLLED STUDY; ERB4 GENE; FEMALE; GENE FUNCTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENOTYPE; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS ONCOGENE;

EID: 82555187795     PISSN: 02785846     EISSN: 18784216     Source Type: Journal    
DOI: 10.1016/j.pnpbp.2017.07.018     Document Type: Erratum

References (30)

1. Banerjee A., Macdonald M.L., Borgmann-Winter K.E., Hahn C.G. Neuregulin 1 erbB4 pathway in schizophrenia: from genes to an interactome. Brain Res Bull 2010, 83:132-139.
2. Barnett J.H., Smoller J.W. The genetics of bipolar disorder. Neuroscience 2009, 164:331-343.
3. Barrett J.C., Fry B., Maller J., Daly M.J. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005, 21:263-265.
4. Baum A.E., Akula N., Cabanero M., Cardona I., Corona W., Klemens B., et al. A genome-wide association study implicates diacylglycerol kinase eta (DGKH) and several other genes in the etiology of bipolar disorder. Mol Psychiatry 2008, 13:197-207.
5. Benzel I., Bansal A., Browning B.L., Galwey N.W., Maycox P.R., McGinnis R., et al. Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct 2007, 3:31.
6. Bublil E.M., Yarden Y. The EGF receptor family: spearheading a merger of signaling and therapeutics. Curr Opin Cell Biol 2007, 19:124-134.
7. Burmeister M., McInnis M.G., Zollner S. Psychiatric genetics: progress amid controversy. Nat Rev Genet 2008, 9:527-540.
8. Carroll L., Owen M. Genetic overlap between autism, schizophrenia and bipolar disorder. Genome Med 2009, 1:102.
9. Elenius K., Corfas G., Paul S., Choi C.J., Rio C., Plowman G.D., et al. A novel juxtamembrane domain isoform of HER4/ErbB4. Isoform-specific tissue distribution and differential processing in response to phorbol ester. J Biol Chem 1997, 272:26761-26768.
10. Ferreira M.A., O'Donovan M.C., Meng Y.A., Jones I.R., Ruderfer D.M., Jones L., et al. Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder. Nat Genet 2008, 40:1056-1058.
11. Hahn C.G., Wang H.Y., Cho D.S., Talbot K., Gur R.E., Berrettini W.H., et al. Altered neuregulin 1-erbB4 signaling contributes to NMDA receptor hypofunction in schizophrenia. Nat Med 2006, 12:824-828.
12. Harrison P.J., Law A.J. Neuregulin 1 and schizophrenia: genetics, gene expression, and neurobiology. Biol Psychiatry 2006, 60:132-140.
13. Huang Y.Z., Won S., Ali D.W., Wang Q., Tanowitz M., Du Q.S., et al. Regulation of neuregulin signaling by PSD-95 interacting with ErbB4 at CNS synapses. Neuron 2000, 26:443-455.
14. Junttila T.T., Sundvall M., Maatta J.A., Elenius K. Erbb4 and its isoforms: selective regulation of growth factor responses by naturally occurring receptor variants. Trends Cardiovasc Med 2000, 10:304-310.
15. Kato T. Molecular genetics of bipolar disorder and depression. Psychiatry Clin Neurosci 2007, 61:3-19.
16. Law A.J., Kleinman J.E., Weinberger D.R., Weickert C.S. Disease-associated intronic variants in the ErbB4 gene are related to altered ErbB4 splice-variant expression in the brain in schizophrenia. Hum Mol Genet 2007, 16:129-141.
17. Lencz T., Morgan T.V., Athanasiou M., Dain B., Reed C.R., Kane J.M., et al. Converging evidence for a pseudoautosomal cytokine receptor gene locus in schizophrenia. Mol Psychiatry 2007, 12:572-580.
18. Muglia P., Tozzi F., Galwey N.W., Francks C., Upmanyu R., Kong X.Q., et al. Genome-wide association study of recurrent major depressive disorder in two European case-control cohorts. Mol Psychiatry 2010, 15:589-601.
19. Norton N., Moskvina V., Morris D.W., Bray N.J., Zammit S., Williams N.M., et al. Evidence that interaction between neuregulin 1 and its receptor erbB4 increases susceptibility to schizophrenia. Am J Med Genet B Neuropsychiatr Genet 2006, 141 B:96-101.
20. O'Donovan M.C., Craddock N., Norton N., Williams H., Peirce T., Moskvina V., et al. Identification of loci associated with schizophrenia by genome-wide association and follow-up. Nat Genet 2008, 40:1053-1055.
21. O'Donovan M.C., Craddock N.J., Owen M.J. Genetics of psychosis; insights from views across the genome. Hum Genet 2009, 126:3-12.
22. Pritchard J.K., Stephens M., Donnelly P. Inference of population structure using multilocus genotype data. Genetics 2000, 155:945-959.
23. Shi Y.Y., He L. SHEsis, a powerful software platform for analyses of linkage disequilibrium, haplotype construction, and genetic association at polymorphism loci. Cell Res 2005, 15:97-98.
24. Shi J., Potash J.B., Knowles J.A., Weissman M.M., Coryell W., Scheftner W.A., et al. Genome-wide association study of recurrent early-onset major depressive disorder. Mol Psychiatry 2011, 16:193-201.
25. Silberberg G., Darvasi A., Pinkas-Kramarski R., Navon R. The involvement of ErbB4 with schizophrenia: association and expression studies. Am J Med Genet B Neuropsychiatr Genet 2006, 141B:142-148.
26. Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J., et al. Molecular cloning of a brain-specific, developmentally regulated neuregulin 1 (NRG1) isoform and identification of a functional promoter variant associated with schizophrenia. J Biol Chem 2007, 282:24343-24351.
27. Tang J.X., Chen W.Y., He G., Zhou J., Gu N.F., Feng G.Y., et al. Polymorphisms within 5′ end of the Neuregulin 1 gene are genetically associated with schizophrenia in the Chinese population. Mol Psychiatry 2004, 9:11-12.
28. The International HapMap Project. Nature 2003/12/20, 789-796. The International HapMap Consortium, [ed2003].
29. Williams N.M., Preece A., Spurlock G., Norton N., Williams H.J., Zammit S., et al. Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia. Mol Psychiatry 2003, 8:485-487.
30. Yu W., Gwinn M., Clyne M., Yesupriya A., Khoury M.J. A navigator for human genome epidemiology. Nat Genet 2008, 40:124-125.